Skip to content
Open access

Biosynthesis of vanillin glucoside in Escherichia coli

Sep 2026 · Synthetic and Systems Biotechnology · Vol 18, pp. 96 - 103 · 0 citations · 40 references
Medicine

TL;DR

This work establishes a modular platform for efficient production of vanillin and its derivatives in E. coli by enhancing SAM biosynthesis, accelerating S-adenosyl-l-homocysteine (SAH) hydrolysis, and establishing methionine regeneration.

Abstract

Vanillin is a widely used flavor compound in the food, cosmetic, and pharmaceutical industries. Although microbial biosynthesis offers a green alternative to conventional chemical synthesis, challenges such as unstable heterologous enzyme expression, insufficient methyl donor supply, and product cytotoxicity limit de novo production. Here, we engineered Escherichia coli to produce vanillyl alcohol, vanillin, and vanillin glucoside directly from glycerol. Genomic integration of the alcohol dehydrogenase ADH6 and multi-copy of the caffeic acid O-methyltransferase COMT gene eliminated the need for plasmid-based expression, yielding 1.09 g/L vanillyl alcohol in shake flasks. To overcome methylation bottlenecks, we reinforced the S-adenosyl-l-methionine (SAM) cycle by enhancing SAM biosynthesis, accelerating S-adenosyl-l-homocysteine (SAH) hydrolysis, and establishing methionine regeneration, which increased vanillyl alcohol production to 1.95 g/L. Subsequent deletion of four endogenous aldehyde-reduction genes together with removal of heterologous ADH6 enabled vanillin accumulation at 551.6 mg/L. Introduction of the glucosyltransferase UGT72E3/2 converted vanillin into vanillin glucoside, reaching 1.37 g/L in shake flasks and 2.12 g/L in a 3-L fed-batch fermenter. This work establishes a modular platform for efficient production of vanillin and its derivatives in E. coli.

Read PDF

Similar papers

Sep 2026

Efficient Production of Vanillyl Alcohol in Escherichia coli via Protein and Pathway Engineering.

Vanillyl alcohol (VNA) is a high-value compound used in the pharmaceutical industry and other fields. Its microbial de novo biosynthesis is severely limited by the low catalytic efficiency of O-methyltransferase. Here, we constructed a V314I mutant of caffeate O-methyltransferase via structure-guided protein engineerin...

Jin-Yi Li, Yong Du, Jia Wang et al. · 0 citations
Oct 2026

Engineering 4-Vinylcatechol Biosynthesis in Escherichia coli Through Host-Enzyme Combination.

De novo biosynthesis of 4-vinylcatechol (VCAT), a valuable bio-based monomer and potent antioxidant, has emerged as a crucial objective due to its profound industrial and pharmacological significance. However, its biosynthesis is frequently hindered by limited precursor availability. In this study, we developed a highl...

E. Kaynak, Merve Seven, Hüseyin Balcı et al. · 0 citations
Open access Sep 2026

Antibiotic- and inducer-free biosynthesis of indican from crude glycerol using engineered probiotic Escherichia coli Nissle 1917

This study demonstrates that the EcN endogenous plasmid engineering eliminates dependence on antibiotics and inducers, establishing a robust and eco-friendly alternative to traditional chemical synthesis.

Li-Jing Mao, Jia-Qi Su, Yu Mo et al. · 0 citations
Oct 2026

Metabolic Engineering of Saccharomyces cerevisiae for Flavonoid Synthesis from Acetate.

This work establishes S. cerevisiae as a viable platform for converting renewable C2 feedstocks into complex flavonoids and provides a practical strategy for the low-carbon bioproduction of high-value natural products.

Mei Li, Guang-Jian Li, Yu-Tao Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.